Keywords: Mrna vaccine
Moderna has agreed to pay up to $2.25 billion to resolve a global patent dispute with Genevant Sciences and Arbutus Biopharma over the lipid nanoparticle technology used in its COVID-19 vaccine, Spikevax. The agreement ends years of litigation over the delivery system that enabled mRNA vaccines during......
An individualized mRNA vaccine has kept most women with triple negative breast cancer in long term remission, according to results published in Nature, offering new evidence that tailored immunotherapy may provide durable protection against one of the most aggressive forms of the disease. The study,......
In a significant medical development, Russia has announced the creation of an innovative mRNA-based cancer vaccine, promising to provide free treatment to patients starting in early 2025. This groundbreaking approach could potentially transform cancer treatment methodologies worldwide. Russian scientists......
-
23:30
-
23:00
-
22:30
-
22:10
-
22:00
-
21:30
-
21:00
-
20:30
-
20:00
-
19:40
-
19:20
-
19:00
-
18:40
-
18:20
-
18:00
-
17:40
-
17:20
-
17:00
-
16:40
-
16:20
-
16:00
-
15:40
-
15:20
-
15:00
-
14:40
-
14:20
-
14:00
-
13:40
-
13:20
-
13:00
-
12:45
-
12:30
-
12:15
-
12:00
-
11:45
-
11:30
-
11:15
-
11:00
-
10:45
-
10:30
-
10:15
-
10:00
-
09:45
-
09:30
-
09:15
-
09:00
-
08:45
-
08:30
-
08:00
